Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05737628 |
Title | First-in-human Dose Escalation and Expansion Study With the SIRPalpha-directed Monoclonal Antibody BYON4228 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Byondis B.V. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | NLD | ITA | GBR | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
ASST Spedali Civili di Brescia | RECRUITING | Brescia | Italy | Details | ||
Amsterdam Universitair Medisch Centrum locatie VUmc | RECRUITING | Amsterdam | Netherlands | Details | ||
Radboud UMC | RECRUITING | Nijmegen | Netherlands | Details | ||
Hospital Universitari Vall d'Hebron | RECRUITING | Barcelona | Spain | Details | ||
Institut Català d'Oncologia | RECRUITING | Barcelona | Spain | Details | ||
Centro Integral Oncológico Clara Campal (CIOCC) Hospital Universitario HM Sanchinarro | RECRUITING | Madrid | Spain | Details | ||
The Christie NHS Foundation Trust | RECRUITING | Manchester | United Kingdom | Details | ||
Derriford Hospital | RECRUITING | Plymouth | United Kingdom | Details |